Publications by authors named "Matthew Sydes"

Claim this Profile
D
Docetaxel with Androgen Deprivation and Radiotherapy in High-risk Localized Prostate Cancer: An ICECaP Individual Patient Data Meta-analysis.
Praful Ravi, Lucia Kwak, Wanling Xie, Anthony D'Amico, James Dignam, Matthew R Sydes

Eur Urol Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standardized and hierarchically classified heart failure and complementary disease monitoring outcome measures: European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart).
Asad Bhatty, Chris Wilkinson, Gorav Batra, Suleman Aktaa, Adam B Smith, Matthew R Sydes

Eur Heart J Qual Care Clin Outcomes· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome measures for randomised clinical trials and multicentre observational studies of cardiovascular diseases published in major clinical journals: systematic review and evidence mapping.
Asad Bhatty, Chris Wilkinson, Suleman Aktaa, Gorav Batra, Benjamin Beska, Matthew R Sydes

Heart· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor transcriptome-wide expression classifiers predict treatment sensitivity in advanced prostate cancers.
Emily Grist, Peter Dutey-Magni, Marina A Parry, Larissa Mendes, Ashwin Sachdeva, Matthew R Sydes

Cell· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digital integration of research conduct into clinical care: results of the PROSPECTOR randomised feasibility study.
Matthew G Wilson, Folkert W Asselbergs, Nausheen Saleem, Lelia Jeilani, David Brealey, Matthew R Sydes

BMJ Evid Based Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duration of Androgen Suppression with Postoperative Radiotherapy (DADSPORT) for Nonmetastatic Prostate Cancer: A Collaborative Systematic Review and Meta-analysis of Aggregate Data.
Sarah Burdett, David J Fisher, Jayne F Tierney, Adrian D Cook, Daniel E Spratt, Matthew R Sydes

Eur Urol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Who is in your trial? Improving the reporting of participant characteristics in trial protocols and results.
Shaun Treweek, Shoba Dawson, Kamlesh Khunti, Murat Akand, Matthias Briel, Matthew R Sydes

Trials· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol.
Silke Gillessen, Laura Murphy, Nicholas D James, Ashwin Sachdeva, Omar El-Taji, Matthew R Sydes

Lancet Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are estimands being correctly used? A review of UK research protocols.
Timothy P Clark, Richard H Wicentowski, Suzie Cro, Matthew R Sydes, Brennan C Kahan

Trials· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External validation of a digital pathology-based multimodal artificial intelligence-derived prognostic model in patients with advanced prostate cancer starting long-term androgen deprivation therapy: a post-hoc ancillary biomarker study of four phase 3 randomised controlled trials of the STAMPEDE platform protocol.
Charles T A Parker, Larissa Mendes, Vinnie Y T Liu, Emily Grist, Songwan Joun, Matthew R Sydes

Lancet Digit Health· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Agreement and utility of coded primary and secondary care data for long-term follow-up of clinical trial outcomes.
Ariel Wang, Anna E Seeley, Matthew R Sydes, Nicholas Jones, Simon de Lusignan

BMC Med Res Methodol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Master protocol for a series of cohort-based randomized controlled trials to test tools to communicate research results to study participants and others with relevant lived experience: the SPIN-CLEAR Trials.
Brett D Thombs, Claire Adams, Elsa-Lynn Nassar, Marie-Eve Carrier, Meira Golberg, Matthew R Sydes

Trials· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Refining Risk Stratification of High-risk and Locoregional Prostate Cancer: A Pooled Analysis of Randomized Trials.
Praful Ravi, Wanling Xie, Marc Buyse, Susan Halabi, Philip W Kantoff, Matthew R Sydes

Eur Urol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer: the STAMPEDE Phase 3 Randomized Clinical Trial.
Gianmarco Leone, Francesco Orlando, Peter Dutey-Magni, Osvaldas Vainauskas, Emily Grist, Matthew R Sydes

JAMA Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Definitions of clinical study outcome measures for cardiovascular diseases: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart).
Chris Wilkinson, Asad Bhatty, Gorav Batra, Suleman Aktaa, Adam B Smith, Matthew R Sydes

Eur Heart J· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomised Trial of No, Short-term, or Long-term Androgen Deprivation Therapy with Postoperative Radiotherapy After Radical Prostatectomy: Results from the Three-way Comparison of RADICALS-HD (NCT00541047).
Chris C Parker, Noel W Clarke, Adrian D Cook, Peter M Petersen, Charles N Catton, Matthew R Sydes

Eur Urol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new trial monitoring plan (TMP) template for clinical trials: output from a Delphi process.
Shiva Taheri, Victoria Yorke-Edwards, Matthew R Sydes, Talia Isaacs, Sharon B Love

Trials· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What is the carbon footprint of academic clinical trials? A study of hotspots in 10 trials.
Jessica Griffiths, Fiona Adshead, Rustam Al-Shahi Salman, Craig Anderson, Emma Bedson, Matthew Robert Sydes

BMJ Open· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges of Using Routinely Collected Healthcare System Data in Randomised Trials.
Christopher P Twine, Haroon Ahmed, Fiona V Lugg-Widger, Cherry-Ann Waldron, Matt J Bown, Matthew R Sydes

Eur J Vasc Endovasc Surg· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Demonstrating the data integrity of routinely collected healthcare systems data for clinical trials (DEDICaTe): A proof-of-concept study.
Macey L Murray, Laura Sato, Jaspal Panesar, Sharon B Love, Rebecca Lee, Matthew R Sydes

Health Informatics J· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The SHOW RESPECT adaptable framework of considerations for planning how to share trial results with participants, based on qualitative findings from trial participants and site staff.
Annabelle South, Claire Snowdon, Eva Burnett, Barbara E Bierer, Katie Gillies, Matthew R Sydes

Trials· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Getting our ducks in a row: The need for data utility comparisons of healthcare systems data for clinical trials.
Matthew R Sydes, Macey L Murray, Saiam Ahmed, Sophia Apostolidou, Judith M Bliss

Contemp Clin Trials· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial.
Chris C Parker, Howard Kynaston, Adrian D Cook, Noel W Clarke, Charles N Catton, Matthew R Sydes

Lancet· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial.
Chris C Parker, Noel W Clarke, Adrian D Cook, Howard Kynaston, Charles N Catton, Matthew R Sydes

Lancet· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Lancet Commission on prostate cancer: planning for the surge in cases.
Nicholas D James, Ian Tannock, James N'Dow, Felix Feng, Silke Gillessen, Matthew R Sydes

Lancet· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis